Some potentially damaging germline variants in these two genes have been reported previously in different other cancer types including CNS tumors, neuroblastoma (MYO3A), and single cases of osteosarcomas and RMSs (MYO5B) [31]. This evidence concerns the gene MYO3A and central nervous system neoplasm.